BIO-TECHNE Corp Net Income Loss

• BIO-TECHNE Corp showed a decrease of -56.3% in Net Income Loss from 2024 to 2025.
• This data is from BIO-TECHNE Corp's annual report (Form 10-K), filed with the SEC on August 22, 2025.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2009 to 2025), BIO-TECHNE Corp's Net Income Loss has declined by 30.3%.
• Historical annual values: Fiscal year 2025: $73.40 million | Fiscal year 2024: $168.11 million | Fiscal year 2023: $285.26 million | Fiscal year 2022: $272.05 million | Fiscal year 2021: $140.41 million | Fiscal year 2020: $229.30 million | Fiscal year 2019: $96.07 million | Fiscal year 2018: $126.15 million | Fiscal year 2017: $76.09 million | Fiscal year 2016: $104.48 million | Fiscal year 2015: $107.74 million | Fiscal year 2014: $110.95 million | Fiscal year 2013: $112.56 million | Fiscal year 2012: $112.33 million | Fiscal year 2011: $112.30 million | Fiscal year 2010: $109.78 million | Fiscal year 2009: $105.24 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026